The University of Sydney
Home >
Closing in on a melanoma cure
Professor Rick Kefford’s early clinical trials of new melanoma drugs that target cell abnormalities represent a leap forward in management of this disease, and could lead to improved quality of life and longer lives for patients.
What matters to you, matters to us.
Join the conversation
Share your thoughts about this topic. Have your say.
Professor Rick Kefford
Director, Westmead Institute for Cancer Research
Co-director of Research, Melanoma Institute of Australia
Find out more
Sydney Medical School
Westmead Institute for Cancer Research
Melanoma Institute Australia
Courses in Medicine and Surgery
Research opportunities in Melanoma research